Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

• Status: Recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

The target population for our study is pregnant women in the first or second trimester with a diagnosis of iron deficiency anemia. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily oral iron supplementation or every other day oral iron supplementation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Medical Branch, Galveston

Criteria

Inclusion Criteria:

• Hemoglobin less than 11 g/dl in the first trimester or less than 10.5 g/dl in the second trimester

• Microcytic anemia

• Singleton gestation in the first or second trimester

Exclusion Criteria:

• Malabsorptive disorder or history of restrictive or malabsorptive gastric surgery

• Known diagnosis of anemia other than iron deficiency (thalassemia, macrocytic, sickle cell, etc.)

• History of cardiopulmonary disease

• Severe anemia requiring parental infusion or transfusion of blood products